Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 09, 2024

BUY
$12.1 - $19.54 $1,512 - $2,442
125 Added 1.22%
10,335 $125,000
Q1 2024

Apr 12, 2024

SELL
$20.51 - $26.65 $10,152 - $13,191
-495 Reduced 4.62%
10,210 $221,000
Q4 2023

Feb 05, 2024

SELL
$19.94 - $26.64 $1,994 - $2,664
-100 Reduced 0.93%
10,705 $279,000
Q3 2023

Oct 25, 2023

SELL
$20.9 - $30.85 $16,615 - $24,525
-795 Reduced 6.85%
10,805 $240,000
Q2 2023

Jul 27, 2023

SELL
$28.37 - $36.31 $20,000 - $25,598
-705 Reduced 5.73%
11,600 $330,000
Q1 2023

Apr 28, 2023

SELL
$32.33 - $37.71 $71,934 - $83,904
-2,225 Reduced 15.31%
12,305 $425,000
Q4 2022

Jan 30, 2023

SELL
$30.52 - $41.79 $16,938 - $23,193
-555 Reduced 3.68%
14,530 $542,000
Q3 2022

Nov 01, 2022

BUY
$31.4 - $42.04 $19,939 - $26,695
635 Added 4.39%
15,085 $474,000
Q2 2022

Jul 15, 2022

SELL
$37.9 - $46.81 $61,966 - $76,534
-1,635 Reduced 10.16%
14,450 $548,000
Q1 2022

Apr 27, 2022

SELL
$44.77 - $54.33 $53,724 - $65,196
-1,200 Reduced 6.94%
16,085 $720,000
Q4 2021

Feb 01, 2022

SELL
$43.72 - $52.25 $50,715 - $60,610
-1,160 Reduced 6.29%
17,285 $902,000
Q3 2021

Oct 29, 2021

SELL
$45.58 - $51.78 $226,031 - $256,777
-4,959 Reduced 21.19%
18,445 $868,000
Q2 2021

Aug 09, 2021

SELL
$50.84 - $56.8 $120,846 - $135,013
-2,377 Reduced 9.22%
23,404 $1.23 Million
Q1 2021

May 11, 2021

SELL
$41.16 - $55.05 $302,896 - $405,112
-7,359 Reduced 22.21%
25,781 $1.42 Million
Q4 2020

Feb 05, 2021

SELL
$33.52 - $44.1 $256,092 - $336,924
-7,640 Reduced 18.73%
33,140 $1.32 Million
Q3 2020

Nov 12, 2020

SELL
$34.67 - $43.16 $478,584 - $595,780
-13,804 Reduced 25.29%
40,780 $1.47 Million
Q2 2020

Aug 05, 2020

SELL
$38.35 - $47.02 $215,181 - $263,829
-5,611 Reduced 9.32%
54,584 $2.31 Million
Q1 2020

May 06, 2020

SELL
$41.02 - $59.59 $210,842 - $306,292
-5,140 Reduced 7.87%
60,195 $2.75 Million
Q4 2019

Feb 12, 2020

SELL
$52.08 - $62.72 $560,641 - $675,180
-10,765 Reduced 14.15%
65,335 $3.85 Million
Q3 2019

Nov 08, 2019

SELL
$49.29 - $58.06 $129,139 - $152,117
-2,620 Reduced 3.33%
76,100 $4.21 Million
Q2 2019

Aug 09, 2019

SELL
$49.34 - $63.49 $75,835 - $97,584
-1,537 Reduced 1.92%
78,720 $4.3 Million
Q1 2019

May 07, 2019

SELL
$59.79 - $74.43 $84,901 - $105,690
-1,420 Reduced 1.74%
80,257 $5.08 Million
Q4 2018

Feb 12, 2019

BUY
$65.26 - $85.69 $4.97 Million - $6.52 Million
76,096 Added 1363.48%
81,677 $5.58 Million
Q4 2018

Feb 11, 2019

SELL
$65.26 - $85.69 $4.97 Million - $6.52 Million
-76,131 Reduced 93.17%
5,581 $5.58 Million
Q3 2018

Nov 07, 2018

SELL
$60.76 - $73.81 $38,582 - $46,869
-635 Reduced 0.77%
81,712 $5.96 Million
Q2 2018

Aug 08, 2018

SELL
$59.7 - $68.0 $152,832 - $174,080
-2,560 Reduced 3.02%
82,347 $4.94 Million
Q1 2018

May 07, 2018

SELL
$65.43 - $80.27 $46,455 - $56,991
-710 Reduced 0.83%
84,907 $5.56 Million
Q4 2017

Feb 12, 2018

BUY
$64.48 - $76.95 $193,697 - $231,157
3,004 Added 3.64%
85,617 $6.22 Million
Q3 2017

Nov 09, 2017

BUY
$77.22 - $82.74 $38,918 - $41,700
504 Added 0.61%
82,613 $6.38 Million
Q2 2017

Aug 11, 2017

BUY
N/A
82,109
82,109 $6.43 Million

Others Institutions Holding WBA

About Walgreens Boots Alliance, Inc.


  • Ticker WBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Pharmaceutical Retailers
  • Shares Outstandng 864,812,992
  • Market Cap $7.13B
  • Description
  • Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products...
More about WBA
Track This Portfolio

Track Folger Nolan Fleming Douglas Capital Management, Inc Portfolio

Follow Folger Nolan Fleming Douglas Capital Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Folger Nolan Fleming Douglas Capital Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Folger Nolan Fleming Douglas Capital Management, Inc with notifications on news.